Global Genetically Modified Drug market size is predicted to grow from US$ 2667 million in 2025 to US$ 3831 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

Global Genetically Modified Drug Market Trends, Growth and Outlook 2025-31

The global Genetically Modified Drug market size is predicted to grow from US$ 2667 million in 2025 to US$ 3831 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031. Drugs made by genetically modified means are also called biological drugs According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Infinity Market Research newest research report, the Genetically Modified Drug Industry Forecast looks at past sales and reviews total world Genetically Modified Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Genetically Modified Drug sales for 2025 through 2031. With Genetically Modified Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetically Modified Drug industry. This Insight Report provides a comprehensive analysis of the global Genetically Modified Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetically Modified Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Genetically Modified Drug market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetically Modified Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetically Modified Drug. This report presents a comprehensive overview, market shares, and growth opportunities of Genetically Modified Drug market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Transgenic Animal &nbsp;&nbsp;&nbsp; Transgenic Plant Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; LFB Biotechnologies SA &nbsp;&nbsp;&nbsp; Pharming Group NV &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Roche &nbsp;&nbsp;&nbsp; Abbott Laboratories &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Merck & Co. &nbsp;&nbsp;&nbsp; Amgen &nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Eli Lilly &nbsp;&nbsp;&nbsp; Takeda &nbsp;&nbsp;&nbsp; Baxter &nbsp;&nbsp;&nbsp; GlaxoSmithKline Key Questions Addressed in this Report What is the 10-year outlook for the global Genetically Modified Drug market? What factors are driving Genetically Modified Drug market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Genetically Modified Drug market opportunities vary by end market size? How does Genetically Modified Drug break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Genetically Modified Drug Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Genetically Modified Drug by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Genetically Modified Drug by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Genetically Modified Drug Segment by Type &nbsp;2.2.1 Transgenic Animal &nbsp;2.2.2 Transgenic Plant &nbsp;2.3 Genetically Modified Drug Sales by Type &nbsp;2.3.1 Global Genetically Modified Drug Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Genetically Modified Drug Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Genetically Modified Drug Sale Price by Type (2020-2025) &nbsp;2.4 Genetically Modified Drug Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.5 Genetically Modified Drug Sales by Application &nbsp;2.5.1 Global Genetically Modified Drug Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Genetically Modified Drug Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Genetically Modified Drug Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Genetically Modified Drug Breakdown Data by Company &nbsp;3.1.1 Global Genetically Modified Drug Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Genetically Modified Drug Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Genetically Modified Drug Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Genetically Modified Drug Revenue by Company (2020-2025) &nbsp;3.2.2 Global Genetically Modified Drug Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Genetically Modified Drug Sale Price by Company &nbsp;3.4 Key Manufacturers Genetically Modified Drug Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Genetically Modified Drug Product Location Distribution &nbsp;3.4.2 Players Genetically Modified Drug Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Genetically Modified Drug by Geographic Region &nbsp;4.1 World Historic Genetically Modified Drug Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Genetically Modified Drug Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Genetically Modified Drug Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Genetically Modified Drug Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Genetically Modified Drug Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Genetically Modified Drug Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Genetically Modified Drug Sales Growth &nbsp;4.4 APAC Genetically Modified Drug Sales Growth &nbsp;4.5 Europe Genetically Modified Drug Sales Growth &nbsp;4.6 Middle East & Africa Genetically Modified Drug Sales Growth 5 Americas &nbsp;5.1 Americas Genetically Modified Drug Sales by Country &nbsp;5.1.1 Americas Genetically Modified Drug Sales by Country (2020-2025) &nbsp;5.1.2 Americas Genetically Modified Drug Revenue by Country (2020-2025) &nbsp;5.2 Americas Genetically Modified Drug Sales by Type (2020-2025) &nbsp;5.3 Americas Genetically Modified Drug Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Genetically Modified Drug Sales by Region &nbsp;6.1.1 APAC Genetically Modified Drug Sales by Region (2020-2025) &nbsp;6.1.2 APAC Genetically Modified Drug Revenue by Region (2020-2025) &nbsp;6.2 APAC Genetically Modified Drug Sales by Type (2020-2025) &nbsp;6.3 APAC Genetically Modified Drug Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Genetically Modified Drug by Country &nbsp;7.1.1 Europe Genetically Modified Drug Sales by Country (2020-2025) &nbsp;7.1.2 Europe Genetically Modified Drug Revenue by Country (2020-2025) &nbsp;7.2 Europe Genetically Modified Drug Sales by Type (2020-2025) &nbsp;7.3 Europe Genetically Modified Drug Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Genetically Modified Drug by Country &nbsp;8.1.1 Middle East & Africa Genetically Modified Drug Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Genetically Modified Drug Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Genetically Modified Drug Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Genetically Modified Drug Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Genetically Modified Drug &nbsp;10.3 Manufacturing Process Analysis of Genetically Modified Drug &nbsp;10.4 Industry Chain Structure of Genetically Modified Drug 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Genetically Modified Drug Distributors &nbsp;11.3 Genetically Modified Drug Customer 12 World Forecast Review for Genetically Modified Drug by Geographic Region &nbsp;12.1 Global Genetically Modified Drug Market Size Forecast by Region &nbsp;12.1.1 Global Genetically Modified Drug Forecast by Region (2026-2031) &nbsp;12.1.2 Global Genetically Modified Drug Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Genetically Modified Drug Forecast by Type (2026-2031) &nbsp;12.7 Global Genetically Modified Drug Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 LFB Biotechnologies SA &nbsp;13.1.1 LFB Biotechnologies SA Company Information &nbsp;13.1.2 LFB Biotechnologies SA Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 LFB Biotechnologies SA Main Business Overview &nbsp;13.1.5 LFB Biotechnologies SA Latest Developments &nbsp;13.2 Pharming Group NV &nbsp;13.2.1 Pharming Group NV Company Information &nbsp;13.2.2 Pharming Group NV Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.2.3 Pharming Group NV Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Pharming Group NV Main Business Overview &nbsp;13.2.5 Pharming Group NV Latest Developments &nbsp;13.3 Pfizer &nbsp;13.3.1 Pfizer Company Information &nbsp;13.3.2 Pfizer Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.3.3 Pfizer Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Pfizer Main Business Overview &nbsp;13.3.5 Pfizer Latest Developments &nbsp;13.4 Roche &nbsp;13.4.1 Roche Company Information &nbsp;13.4.2 Roche Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.4.3 Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Roche Main Business Overview &nbsp;13.4.5 Roche Latest Developments &nbsp;13.5 Abbott Laboratories &nbsp;13.5.1 Abbott Laboratories Company Information &nbsp;13.5.2 Abbott Laboratories Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.5.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Abbott Laboratories Main Business Overview &nbsp;13.5.5 Abbott Laboratories Latest Developments &nbsp;13.6 Johnson & Johnson &nbsp;13.6.1 Johnson & Johnson Company Information &nbsp;13.6.2 Johnson & Johnson Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.6.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Johnson & Johnson Main Business Overview &nbsp;13.6.5 Johnson & Johnson Latest Developments &nbsp;13.7 Merck & Co. &nbsp;13.7.1 Merck & Co. Company Information &nbsp;13.7.2 Merck & Co. Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.7.3 Merck & Co. Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Merck & Co. Main Business Overview &nbsp;13.7.5 Merck & Co. Latest Developments &nbsp;13.8 Amgen &nbsp;13.8.1 Amgen Company Information &nbsp;13.8.2 Amgen Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.8.3 Amgen Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Amgen Main Business Overview &nbsp;13.8.5 Amgen Latest Developments &nbsp;13.9 F. Hoffmann-La Roche &nbsp;13.9.1 F. Hoffmann-La Roche Company Information &nbsp;13.9.2 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 F. Hoffmann-La Roche Main Business Overview &nbsp;13.9.5 F. Hoffmann-La Roche Latest Developments &nbsp;13.10 Sanofi &nbsp;13.10.1 Sanofi Company Information &nbsp;13.10.2 Sanofi Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.10.3 Sanofi Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Sanofi Main Business Overview &nbsp;13.10.5 Sanofi Latest Developments &nbsp;13.11 Novartis &nbsp;13.11.1 Novartis Company Information &nbsp;13.11.2 Novartis Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.11.3 Novartis Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Novartis Main Business Overview &nbsp;13.11.5 Novartis Latest Developments &nbsp;13.12 Eli Lilly &nbsp;13.12.1 Eli Lilly Company Information &nbsp;13.12.2 Eli Lilly Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.12.3 Eli Lilly Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Eli Lilly Main Business Overview &nbsp;13.12.5 Eli Lilly Latest Developments &nbsp;13.13 Takeda &nbsp;13.13.1 Takeda Company Information &nbsp;13.13.2 Takeda Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.13.3 Takeda Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Takeda Main Business Overview &nbsp;13.13.5 Takeda Latest Developments &nbsp;13.14 Baxter &nbsp;13.14.1 Baxter Company Information &nbsp;13.14.2 Baxter Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.14.3 Baxter Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Baxter Main Business Overview &nbsp;13.14.5 Baxter Latest Developments &nbsp;13.15 GlaxoSmithKline &nbsp;13.15.1 GlaxoSmithKline Company Information &nbsp;13.15.2 GlaxoSmithKline Genetically Modified Drug Product Portfolios and Specifications &nbsp;13.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 GlaxoSmithKline Main Business Overview &nbsp;13.15.5 GlaxoSmithKline Latest Developments 14 Research Findings and Conclusion

Report	Global Genetically Modified Drug Market Growth 2025-2031
Selected License	Multi ID: LPI38817

Buyer Information

Order Summary